SCHEMBL18667702

SCHEMBL18667702

c1ccc(-n2c3cc4ccccc4cc3c3c4ccccc4c4ccccc4c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
CYP1A2 P05177 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDR P35968 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
MAT2A P31153 3/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE7A Q13946 1/20 0.33
PDE7B Q9NP56 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18667701 0.91 HTR6 (0.35) L3MBTL1KDM4EATMMAPK1ALDH1A1
SCHEMBL18668061 0.89 KDM4E (0.46) L3MBTL1KDM4EATMALDH1A1TSHR
SCHEMBL18668067 0.89 KDM4E (0.47) L3MBTL1KDM4EATMMAPK1ALDH1A1
SCHEMBL19131235 0.89 L3MBTL1 (0.40) L3MBTL1KDM4EATMMAPK1ALDH1A1
SCHEMBL18667717 0.88 HTR1A (0.37) L3MBTL1KDM4EATMMAPK1ALDH1A1
SCHEMBL19844142 0.88 KDM4E (0.46) L3MBTL1KDM4EATMMAPK1ALDH1A1
SCHEMBL18668057 0.88 CYP2A6 (0.38) L3MBTL1KDM4EMAPK1ALDH1A1CYP1A2
SCHEMBL18667686 0.88 MAPK10 (0.38) KDM4EMAPK1ALDH1A1HPGDMAT2A
SCHEMBL18668027 0.87 CYP1A2 (0.33) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL18667704 0.87 HTR3A (0.38) ALDH1A1CYP1A2THRBHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
WO-2017047992-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2017-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 L3MBTL1 856/4885KDM4E 2554/4885ATM 3310/4885
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 L3MBTL1 856/4885KDM4E 2554/4885ATM 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.